Science and Enterprise

Tag: university

  • Allied-Bristol Licensing Immunotherapy Technology

    27 August 2015. Allied-Bristol Life Sciences, a joint venture of science commercialization company Allied Minds and Bristol-Myers Squibb, is licensing a new type of synthetic chemistry technology from Yale University that can stimulate the immune system to treat cancer. Financial details of the licensing agreement were not disclosed. The agreement covers a technology known as…

  • Injected Gel Designed to Deliver Cancer Therapy

    26 August 2015. Biomedical engineers at Harvard University devised a hydrogel material that when infused with tumor and immune-system cells can stimulate a therapeutic immune response in lab mice. The team from Harvard’s Wyss Institute, a biomedical engineering research center, published its findings earlier this month in the journal Nature Communications (paid subscription required). The…

  • Alerts in Health Records Cut Delays in Cancer Diagnosis

    25 August 2015. Medical researchers found electronic triggers that alert physicians when test results suggest a potential for cancer, reduce delays for patients needing follow-up care. The team led by Hardeep Singh, a professor at Baylor College of Medicine in Houston, published its findings yesterday in Journal of Clinical Oncology (paid subscription required). In addition…

  • All-Purpose Hand-Held Device Checks for Vital Signs

    24 August 2015. Biomedical engineers at Johns Hopkins University in Baltimore developed a portable device that quickly returns a person’s vital health indicators in an ambulance, at an outpatient clinic, or even at home. Test results of the device, called MouthLab, led by biomedical engineering and of otolaryngology professor Gene Fridman, appear in the September…

  • Antipsychotic Drug Savings Expected as Patents Expire

    21 August 2015. Medicaid is expected to save nearly $3 billion by the year 2019 from patents expiring on leading branded antipsychotic drugs, and as generic forms of those drugs replace them. Researchers from University of Maryland medical school in Baltimore made those calculations in a paper published last month in the journal Psychiatric Services…

  • Biomedical Accelerator Accepts 12 New Research Projects (Updated)

    20 August 2015, Updated 21 August 2015 (see below). The Blavatnik Biomedical Accelerator at Harvard University is adding 12 new campus research projects to transform their findings into marketable products and services. The accelerator aims to bridge the gap between academic labs and venture financing, often called the Valley of Death because of the lack…

  • NSF Funds Math Tutoring Software Commercialization

    18 August 2015. Software to help primary and secondary school students learn mathematics is receiving financial support from National Science Foundation to bring the software to market. NSF awarded a grant of nearly $200,000 to Beverly Woolf, a computer scientist at University of Massachusetts in Amherst, for the 18-month project. Woolf is developer of the…

  • Wireless Light-Activated Circuit Connects to Mice Neurons

    17 August 2015. Engineers at Stanford University designed a wireless circuit implanted under the skin for sending light-activated signals to nerve cells in lab mice. The team led by electrical engineering professor Ada Poon published its findings in today’s issue of the journal Nature Methods (paid subscription required). Poon and colleagues are seeking a simple,…

  • Oilseed Plant Engineered for Biofuel, Chemical Feedstocks

    14 August 2015. A biochemistry lab at Kansas State University genetically engineered camelina oilseed plants to make them better feedstocks for biofuels and chemicals. The team led by Kansas State professor Timothy Durrett published its findings in the August issue of the journal Plant Biotechnology Journal (paid subscription required). Durrett, with colleagues from University of…

  • Blood Disease Biotech Gains $120 Million in IPO

    12 August 2015. Global Blood Therapeutics, a biotechnology company developing treatments for blood-related disorders, is raising $120 million in its initial public stock offering. The company, in South San Francisco, California and trading on the Nasdaq exchange under the symbol GBT, issued 6 million shares priced at $20.00. Shares closed today trading at $43.50, more…